Novartis to Invest $1.25 billion in China

Tue, 11/03/2009 - 3:44am
BASEL, Switzerland (AP) — Novartis AG said Tuesday it will invest $1.25 billion in its research centers in China over the next five years. The company said it will spend $1 billion expanding the Novartis Institute of BioMedical Research in Shanghai, which specializes in the research of diseases particularly prevalent in China. Another $250 million will be invested in a new technical facility in Changshu, which researches, develops and manufactures active pharmaceutical ingredients, said Novartis. "We are confident that our expanded investment in R&D will result in innovative therapies for patients in China and other countries nurtured by the growing scientific excellence in China," said Chief Executive Daniel Vasella.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.